FDA Approves Momenta/Sandoz' Lovenox Generic Without Need For Clinical Studies
This article was originally published in The Pink Sheet Daily
Executive Summary
Agency's five criteria for determining "sameness" of generic enoxaparin to Sanofi-Aventis's low molecular weight heparin could serve as guideposts for future biosimilar approvals.